ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Aptuit buys another drug services firm

by Michael McCoy
May 16, 2016 | APPEARED IN VOLUME 94, ISSUE 20

In its second deal in as many months, the pharmaceutical services firm Aptuit has acquired Kuecept, a London-based provider of preformulation testing, preclinical dose-vehicle screening, and formulation development. Kuecept claims skill in using milligram quantities of active pharmaceutical ingredient to develop “robust and practical” drug formulations. Last month, Aptuit acquired Exquiron Biotech, a Swiss company with expertise in assay development, high-throughput screening, selectivity testing, and hit characterization.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment